Hikma Pharmaceuticals Plc Holding(s) in Company (9963O)

TIDMHIK

RNS Number : 9963O

Hikma Pharmaceuticals Plc

25 August 2017

TR-1: Standard form for notification of major holdings

LONDON, 25 August 2017 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX: HIK) (LEI: 549300BNS685UXH4JI75), the fast-growing multinational pharmaceuticals group, announces as follows:

NOTIFICATION OF MAJOR HOLDINGS

 
 1. Identity of the issuer or                                Hikma Pharmaceuticals PLC 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
----------------------------------------------------------  --------------------------- 
 2. Reason for the notification (please tick the appropriate 
  box or boxes): 
--------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                             YES 
-----------------------------------------------------------  -------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
-----------------------------------------------------------  -------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
-----------------------------------------------------------  -------------------------- 
 An event changing the breakdown of voting rights 
-----------------------------------------------------------  -------------------------- 
 Other (please 
  specify): 
---------------------------------------------------------    -------------------------- 
 3. Full name of person(s)                                   Vanguard Health Care Fund 
  subject to the 
  notification obligation: 
  (iii) 
----------------------------------------------------------  --------------------------- 
 4. Full name of shareholder(s) 
  (if different from 3.):(iv) 
----------------------------------------------------------  --------------------------- 
 5. Date of the transaction                                  22 August 2017 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
----------------------------------------------------------  --------------------------- 
 6. Date on which issuer                                     24 August 2017 
  notified: 
----------------------------------------------------------  --------------------------- 
 7. Threshold(s) that is/are 
  crossed or 
  reached: (vi, vii)                                         3% 
----------------------------------------------------------  --------------------------- 
 
 
 
 8. Notified details: 
-------------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
-------------------------------------------------------------------------------------------------------------------------- 
 Class/type        Situation previous                Resulting situation after the 
  of                to the triggering                 triggering transaction 
  shares            transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
----------------  --------------------------------  ---------------------------------------------------------------------- 
                   Number           Number           Number             Number of                   % of voting 
                    of               of               of shares          voting                      rights (x) 
                    Shares           Voting                              rights 
                                     Rights 
--------------    ---------------  ---------------  -----------------  --------------------------  ----------------------- 
                                                     Direct             Direct (xi)    Indirect     Direct      Indirect 
                                                                                        (xii) 
--------------      -----------      -----------    -----------------  -------------  -----------  ----------  ----------- 
 
 
   GB00B0LCW083      7,186,729        7,186,729         7,284,981        7,284,981                    3.03% 
                  ---------------  ---------------  -----------------  -------------  -----------  ----------  ----------- 
 
 
 B: Qualifying Financial Instruments 
-------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------------------- 
 Type of financial   Expiration       Exercise/                       Number of voting                % of voting 
  instrument          date             Conversion                      rights that                     rights 
                      (xiii)           Period (xiv)                    may be 
                                                                       acquired if 
                                                                       the 
                                                                       instrument 
                                                                       is 
                                                                       exercised/ 
                                                                       converted. 
------------------  ---------------  ------------------------------  ------------------------------  --------------------- 
 N/A 
------------------  ---------------  ------------------------------  ------------------------------  --------------------- 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
-------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------------------- 
 Type of         Exercise         Expiration       Exercise/        Number of voting                % of voting 
 financial       price            date             Conversion        rights instrument               rights (xix, 
 instrument                       (xvii)           period            refers to                       xx) 
                                                   (xviii) 
--------------  ---------------  ---------------  ---------------  ------------------------------  ----------------------- 
 N/A                                                                                                Nominal       Delta 
--------------  ---------------  ---------------  ---------------  ------------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
-------------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                                            Percentage of voting rights 
-----------------------------------------------------------------  ------------------------------------------------------- 
 7,284,981                                                          3.03% 
-----------------------------------------------------------------  ------------------------------------------------------- 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
-------------------------------------------------------------------------------------------------------------------------- 
 
   N/A 
 
 Proxy Voting: 
-------------------------------------------------------------------------------------------------------------------------- 
 10. Name of the proxy holder:                                            N/A 
-----------------------------------------------------------------------  ------------------------------------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
-----------------------------------------------------------------------  ------------------------------------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
-----------------------------------------------------------------------  ------------------------------------------------- 
 
 
  13. Additional information: 
----------------------------------------------------  -------------------------------------------------------------------- 
 14. Contact name:                                     Vanguard Health Care Fund 
                                                        c/o The Vanguard Group, Inc. 
                                                        [e-mail] 
----------------------------------------------------  -------------------------------------------------------------------- 
 
 15. Contact telephone number:                           +001 [phone] 
----------------------------------------------------  -------------------------------------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUVOBRBVAWURR

(END) Dow Jones Newswires

August 25, 2017 03:41 ET (07:41 GMT)